Page last updated: 2024-10-22

amlexanox and Neoplasms

amlexanox has been researched along with Neoplasms in 2 studies

amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Amlexanox (AMX) is an azoxanthone drug used for decades for the treatment of mouth aphthous ulcers and now considered for the treatment of diabetes and obesity."2.82The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives. ( Bailly, C, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bailly, C1
Guo, Y1
Jin, S1
Song, D1
Yang, T1
Hu, J1
Hu, X1
Han, Q1
Zhao, J1
Guo, Z1
Wang, X1

Reviews

1 review available for amlexanox and Neoplasms

ArticleYear
The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives.
    Biochemical pharmacology, 2022, Volume: 197

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Neoplasms; Treatment

2022

Other Studies

1 other study available for amlexanox and Neoplasms

ArticleYear
Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells.
    European journal of medicinal chemistry, 2022, Nov-15, Volume: 242

    Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-As

2022